Similarly, enhanced Cthrc1 expression [130] or treatment of keloid fibroblasts with recombinant Cthrc1 [129] decreased collagen I synthesis in both normal skin fibroblasts and keloid fibroblasts in vitro by inhibiting TGF-β/Smad pathway activation. The gene discussed is CTHRC1; the disease is keloid.